Dermapharm

Dermapharm AG is a specialized pharmaceutical company founded in 1991, focusing on health, skin care, allergies, and environmental concerns. The company's product portfolio includes topical dermatological treatments, vitamin D supplements, and formulations for nerve regeneration and cardiovascular health. Dermapharm is committed to delivering innovative pharmaceutical solutions designed to meet individual health requirements, serving both patients seeking effective treatments and healthcare professionals requiring reliable medical supplies. Their operations are supported by a workforce of 1,000 - 5,000 employees, contributing to their market presence.

With a reported revenue of $1.2B, Dermapharm operates with a significant financial scale within the healthcare sector. The company's strategic focus on niche therapeutic areas allows it to develop and market specialized products. Dermapharm's commitment to quality and innovation is central to its business model, aiming to enhance patient well-being through its pharmaceutical offerings. Meet Dermapharm's team to understand the expertise driving their product development and market strategy.

The company's industry classification spans Pharmaceuticals and Healthcare, with a strong emphasis on B2B operations and branded pharmaceutical products. Dermapharm's market presence extends across Europe, including Germany, the UK, and Switzerland, positioning it as a key player in its specialized segments. Their product development pipeline and market penetration strategies are geared towards sustained growth and leadership in their chosen therapeutic domains.